ScholarIQanswers from OpenAlex

Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non–small Cell Lung Cancer

PaperCitations, authors & open-access status

Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non–small Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non–small Cell Lung Cancer have?

ScholarIQcitation count

Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non–small Cell Lung Cancer has 31 citations in the OpenAlex counts ScholarIQ stores.

When was Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non–small Cell Lung Cancer published?

ScholarIQyear

Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non–small Cell Lung Cancer has 2018 year in the ScholarIQ index.

What is the open-access status of Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non–small Cell Lung Cancer?

ScholarIQoa status

Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non–small Cell Lung Cancer has bronze oa status in the ScholarIQ index.

What is the DOI of Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non–small Cell Lung Cancer?

ScholarIQdoi

The DOI for Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non–small Cell Lung Cancer is on the source record.

What is the PMID of Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non–small Cell Lung Cancer?

ScholarIQpmid

The PMID for Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non–small Cell Lung Cancer is on the source record.

What is the OpenAlex record for Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non–small Cell Lung Cancer?

ScholarIQopenalex

The OpenAlex for Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non–small Cell Lung Cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial